New Study Highlights Patient Satisfaction and Clinical Feasibility of Noona
Centerline
A clinical trial using Varian’s Noona® solution for patient engagement assesses the impact of ePROs on healthcare utilization and clinical burden.
更多資訊Expanded Intracranial Applications for HyperArc Therapy
Centerline
Introduced in 2017 to help simplify SRS treatment planning and delivery for multiple brain metastases, HyperArc high-definition radiosurgery is now proving effective at treating benign intracranial lesions.
更多資訊An Industry/Academic Partnership Yields Fruit: An Ultra-High Dose Rate Beam Monitoring Tool for FLASH Trials
Centerline
Varian, in partnership with the Danish Centre for Particle Therapy (DCPT) at Aarhus University Hospital and the Cincinnati Children’s Hospital/UC Health Proton Therapy Center—two members of the FlashForward™ Consortium—has tested a specialized dose monito...
更多資訊Adaptive Radiotherapy Post-COVID: An Interview with Professor Patricia Price
Centerline
As many facilities move back towards normal operations after COVID restrictions, Professor Pat Price, a leading expert on radiation oncology, discusses what that means for adaptive radiotherapy.
更多資訊Royal Surrey NHS Foundation Trust, Guildford, UK: Focusing on Patients Who Will Benefit Most
Centerline
The Royal Surrey County Hospital comprises two sites about 20 miles apart in the county of Surrey, UK. Across the two sites, radiotherapy clinicians treat about 3,500 patients a year, typically with IMRT or RapidArc® radiotherapy, including stereotactic a...
更多資訊Henry Ford Cancer Institute (HFCI), Michigan: Looking Towards Adaptation During Five-Fraction SBRT
Centerline
Henry Ford Allegiance (HFA) is a community-based hospital about 60 miles west of the main Henry Ford Health System campus. Its HFCI radiation oncology clinic treats approximately 450 patients a year, with more than 9,000 external beam treatments delivered...
更多資訊Royal North Shore Hospital, Sydney, Australia: Adapting to Changes in the Target
Centerline
The Royal North Shore Hospital in Sydney, Australia, also deployed its Ethos™ therapy system about a year ago. Royal North Shore is a small, state-funded facility that treats about 1,500 cancer patients a year and its head of medical physics, Assistant P...
更多資訊Icon Group, Australia: Choosing Adaptive Fractions 98 Percent of The Time
Centerline
Icon Group operates 30 cancer centers in Australia, one in New Zealand, six in Singapore, four in Mainland China, and two in Hong Kong, with several in development across their international network.
更多資訊The Treatment Adapts so the Patient Doesn’t Have To: Ethos at Queen’s Hospital, Romford, UK
Centerline
Queens Hospital treats around 1,200 patients a year and was the first facility in the UK to deploy and start using an Ethos™ therapy system in August 2020, despite being in the midst of the COVID pandemic.
更多資訊Ethos Adaptive Radiotherapy: Redefining Cancer Treatment
Centerline
The use of online adaptive radiotherapy has expanded around the world since Varian introduced Ethos™ therapy at ASTRO in 2019. Through groups such as the Adaptive Intelligence Consortium, research continues to show that adaptive treatment can enable dose ...
更多資訊